# NEOSTIGMINE METHYLSULFATE

NDC: 0548-9602
Generic name: neostigmine methylsulfate
Labeler / Manufacturer: Amphastar Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20170925

FDA application: ANDA209933

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0548-9602"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0548-9602
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e47a4a4c-0e7c-40b6-9950-5b3adadcac22